Ubs Asset Management Americas Inc X Biotech Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in X Biotech Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 253,770 shares of XBIT stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
253,770
Previous 248,270
2.22%
Holding current value
$1.62 Million
Previous $1.28 Million
53.68%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XBIT
# of Institutions
49Shares Held
4.87MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$7.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$6.78 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA452KShares$2.89 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny281KShares$1.79 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$1.58 Million0.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $194M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...